Abstract
Vascular endothelial growth factor (VEGF) is a major regulator of angiogenesis. Previous studies have shown that the ability of murine embryonic stem (ES) cells to form teratocarcinomas in nude mice is substantially reduced following targeted inactivation of the VEGF gene. We sought to determine whether VEGF−/− ES cells' tumorigenic phenotype can be rescued by transfection with a mutant H-ras.VEGF−/− ES cells were transfected with expression vector which directs the constitutive synthesis of oncogenic Val-12ras.Expression ofrasprotein was documented by Western blot analysis. We injected several clones with different levels of Val-12rasexpression in nude mice. In agreement with our earlier report, VEGF−/− ES cells formed much smaller tumors than control ES cells. However, none of theras-expressing clones tested formed tumors larger than those derived from parental VEGF−/− cells. Thus, pluripotent cells such as ES cells are unable to compensate for the loss of VEGF even in the presence of a potent oncogenic stimulus such as mutantras.These findings strengthen the hypothesis that VEGF-mediated angiogenesis is crucial for effectivein vivotumor growth.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: Biochemical and Biophysical Research Communications
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.